XML 19 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Issuances of Common Stock
A summary of the status of stock option activity for the three months ended March 31, 2020 is as follows (in thousands, except price data):
SharesWeighted-average
exercise price
per share
Outstanding at December 31, 2019944  $30.63  
Granted121  77.16  
Exercised(65) 21.26  
Forfeited(12) 43.34  
Outstanding at March 31, 2020988  $36.77  
A summary of the status of restricted stock unit activity for the three months ended March 31, 2020 is as follows (in thousands, except price data):
SharesWeighted-average
grant date fair value
Non-vested December 31, 2019786  $41.88  
Granted186  77.53  
Vested(60) 18.21  
Forfeited(17) 49.85  
Non-vested at March 31, 2020895  $50.74  
During the three months ended March 31, 2020, the Company issued 27,826 shares of common stock in connection with the Company’s employee stock purchase plan (the “ESPP”).
Stock-Based Compensation
The expense related to the Company’s stock-based compensation plans included in the accompanying Consolidated Statements of Income was as follows (in thousands):
Three Months Ended
March 31,
20202019
Cost of sales$258  $280  
Research and development642  565  
Sales and marketing1,297  1,119  
General and administrative1,681  1,624  
Total stock-based compensation expense$3,878  $3,588  
As of March 31, 2020, total unrecognized compensation expense was $35.7 million, which is expected to be recognized over a weighted-average period of approximately 2.8 years.
The estimated fair value of each stock option was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants.
Three Months Ended
March 31,
20202019
Risk-free interest rate1.35 %2.51 %
Expected option life (in years)5.145.68
Volatility rate39 %39 %
Dividend rate%%
Weighted-average grant date fair value$28.24  $23.67  
The fair value of RSUs is determined based on the closing market price of the Company’s common stock on the grant date. The weighted-average fair value of RSUs granted during the three months ended March 31, 2020 and 2019 was $77.53 and $59.45, respectively.
Compensation expense capitalized to inventory and compensation expense related to the Company’s ESPP were not material for the three months ended March 31, 2020 or 2019.